Conolidine’s analgesic results stem from its conversation with non-opioid pain pathways. Not like opioids, which bind to µ-opioid receptors within the central nervous program, conolidine modulates alternate molecular targets. A Science Improvements research found that conolidine interacts Using the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availability. By https://gustaveu320dgh2.mycoolwiki.com/user